Extensive catalog of primary and secondary antibodies

Established in 1997, GeneTex, Inc. began operating in San Antonio, Texas. GeneTex was founded by three internationally renowned scientists with recognized expertise in clinical oncology, cancer biology, and infectious diseases. Drawing on her extensive experience and research interests, the company’s initial focus was the development of prognostic biomarkers for the study of breast cancer biology. Over time, the company evolved to incorporate a full portfolio of uses used by scientists studying the mechanisms underlying many types of cancer.

The GeneTex product portfolio has expanded to cover research areas including cancer, cell biology, epigenetics, immunology, infectious diseases, metabolism, neuroscience, signaling pathways,stem cells development and Zebrafish.

In 2009, GeneTex moved to Irvine, California, to be present in the largest biotech hub in the world. In 2011, GeneTex grew to become a multinational organization and one of the largest antibody manufacturers with a global distribution network.